1
|
Giselbrecht J, Jähne S, Bergmann M, Meli ML, Pineroli B, Boenzli E, Teichmann-Knorrn S, Zablotski Y, Pennisi MG, Layachi N, Serra R, Bo S, Hofmann-Lehmann R, Hartmann K. Prevalence of Different Courses of Feline Leukaemia Virus Infection in Four European Countries. Viruses 2023; 15:1718. [PMID: 37632060 PMCID: PMC10459464 DOI: 10.3390/v15081718] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/23/2023] [Revised: 08/07/2023] [Accepted: 08/08/2023] [Indexed: 08/27/2023] Open
Abstract
Prevalence of progressive feline leukaemia virus (FeLV) infection is known to still be high in cats in Europe, especially in Southern Europe, but the prevalence of other outcomes of FeLV infection has not been determined in most countries. The present study aimed to investigate the prevalence of progressive, regressive, abortive, and focal infection in four European countries, two with a high (Italy, Portugal) and two with a low expected prevalence (Germany, France). Blood samples of 934 cats (Italy: 269; Portugal: 240; France: 107; Germany: 318) were evaluated for the p27 antigen, as well as anti-whole virus, anti-SU, and anti-p15E antibodies by enzyme-linked immunosorbent assay (ELISA) in serum and for proviral DNA by quantitative polymerase chain reaction (qPCR) in whole blood. Positive p27 antigen ELISA results were confirmed by reverse transcriptase-qPCR (RT-qPCR) detecting viral RNA in saliva swabs and/or blood. The outcome of FeLV infection was categorised as progressive (antigen-positive, provirus-positive), regressive (antigen-negative, provirus-positive), abortive (antigen- and provirus-negative, antibody-positive), and focal (antigen-positive, provirus-negative) infection. Overall FeLV prevalence was 21.2% in Italy, 20.4% in Portugal, 9.5% in Germany, and 9.3% in France. Prevalence of progressive, regressive, abortive, and focal infection in Italy was 7.8%, 4.5%, 6.3%, and 2.6%; in Portugal 3.8%, 8.3%, 6.7%, and 1.7%; in Germany 1.9%, 1.3%, 3.5%, and 2.8%; in France 1.9%, 3.7%, 2.8%, and 0.9%, respectively. In conclusion, overall FeLV prevalence is still very high, especially in Southern European countries. Therefore, testing, separation of infected cats, and vaccination are still important measures to reduce the risk of FeLV infection.
Collapse
Affiliation(s)
- Juliana Giselbrecht
- LMU Small Animal Clinic, Centre for Clinical Veterinary Medicine, 80539 Munich, Germany; (S.J.); (M.B.); (Y.Z.); (K.H.)
| | - Stéphanie Jähne
- LMU Small Animal Clinic, Centre for Clinical Veterinary Medicine, 80539 Munich, Germany; (S.J.); (M.B.); (Y.Z.); (K.H.)
| | - Michèle Bergmann
- LMU Small Animal Clinic, Centre for Clinical Veterinary Medicine, 80539 Munich, Germany; (S.J.); (M.B.); (Y.Z.); (K.H.)
| | - Marina L. Meli
- Clinical Laboratory, Department of Clinical Diagnostics and Services, and Centre for Clinical Studies, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland; (M.L.M.); (B.P.); (E.B.); (R.H.-L.)
| | - Benita Pineroli
- Clinical Laboratory, Department of Clinical Diagnostics and Services, and Centre for Clinical Studies, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland; (M.L.M.); (B.P.); (E.B.); (R.H.-L.)
| | - Eva Boenzli
- Clinical Laboratory, Department of Clinical Diagnostics and Services, and Centre for Clinical Studies, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland; (M.L.M.); (B.P.); (E.B.); (R.H.-L.)
| | | | - Yury Zablotski
- LMU Small Animal Clinic, Centre for Clinical Veterinary Medicine, 80539 Munich, Germany; (S.J.); (M.B.); (Y.Z.); (K.H.)
| | | | | | - Rodrigo Serra
- Investigacao Veterinaria Independente, 1700-119 Lisbon, Portugal;
| | - Stefano Bo
- Ambulatorio Veterinario Bo-Ferro, 10123 Turin, Italy;
| | - Regina Hofmann-Lehmann
- Clinical Laboratory, Department of Clinical Diagnostics and Services, and Centre for Clinical Studies, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland; (M.L.M.); (B.P.); (E.B.); (R.H.-L.)
| | - Katrin Hartmann
- LMU Small Animal Clinic, Centre for Clinical Veterinary Medicine, 80539 Munich, Germany; (S.J.); (M.B.); (Y.Z.); (K.H.)
| |
Collapse
|
2
|
Schäfer I, Schmidt A, Gräßer F, Schieszler A, Aupperle-Lellbach H, Loesenbeck G, Gentil M, Müller E, Naucke TJ. Feline leishmaniosis with focus on ocular manifestation: a case report. Parasit Vectors 2023; 16:161. [PMID: 37173777 PMCID: PMC10176290 DOI: 10.1186/s13071-023-05741-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2023] [Accepted: 03/15/2023] [Indexed: 05/15/2023] Open
Abstract
BACKGROUND In Europe, feline leishmaniosis is commonly caused by Leishmania infantum. There is little knowledge regarding pathogenesis, ocular manifestations and long-term follow-ups in cats with leishmaniosis. FINDINGS A 6-year-old female, spayed European Shorthair cat was imported from Spain to Germany 2 years prior to its first clinical presentation. The cat showed lethargy, weight loss, ulcerative lesions on the front limbs and high-grade chronic uveitis. The diagnosis of L. infantum infection was based on the cytological finding of amastigotes in skin lesions, positive qPCR of EDTA-blood and positive PCR of a cyto-brush sample from the conjunctiva. Supportive findings included positive serology by IFAT, serum protein capillary electrophoresis with peaks in alpha2- and gamma-globulin sections and marked elevation of SAA. Enucleation had to be performed on day 288 on both eyes because of blindness, glaucoma and high-grade uveitis. Histologically, high numbers of Leishmania spp. amastigotes were found in histiocytes. IFAT and PCR were positive in the aqueous humor in both eyes, respectively. Feline leukemia virus antigen and feline immunodeficiency virus antibody testings were positive. Hematological and biochemical results revealed mild leukocytosis with lymphocytosis, monocytosis and eosinopenia as well as marked elevation of SAA and hyperglobulinemia. The cat was treated with allopurinol, responded well and was still alive at follow-up on day 288 after first presentation. However, enucleation was necessary because of refractory glaucoma and uveitis. CONCLUSION: For the first time, ocular evidence of Leishmania IgG antibodies was demonstrated in the aqueous humor of both eyes in cats. There is limited knowledge about the pathogenesis, treatment options and outcomes in cats infected with L. infantum. This case report supports the hypothesis that immunosuppression increases the risk of clinical signs of leishmaniasis in cats. Alpha2- and gamma-globulin peaks in serum protein capillary electrophoresis are supportive criteria for the diagnosis of L. infantum infection. SAA is valuable for monitoring. Regarding ophthalmology, uveitis and glaucoma may have a poor prognosis.
Collapse
Affiliation(s)
- Ingo Schäfer
- LABOKLIN GmbH and Co. KG, Bad Kissingen, Germany.
| | - Albert Schmidt
- Small Animal Practice Dr. Fritz Gräßer, Großostheim, Germany
| | - Fritz Gräßer
- Small Animal Practice Dr. Fritz Gräßer, Großostheim, Germany
| | | | | | | | | | | | | |
Collapse
|
3
|
Mekata H, Umeki K, Yamada K, Umekita K, Okabayashi T. Nosocomial Severe Fever with Thrombocytopenia Syndrome in Companion Animals, Japan, 2022. Emerg Infect Dis 2023; 29:614-617. [PMID: 36823498 PMCID: PMC9973679 DOI: 10.3201/eid2903.220720] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/25/2023] Open
Abstract
In Japan, 2 cats that underwent surgery in a room where a sick dog had been euthanized became ill within 9 days of surgery. Severe fever with thrombocytopenia syndrome virus was detected in all 3 animals; nucleotide sequence identity was 100%. Suspected cause was an uncleaned pulse oximeter probe used for all patients.
Collapse
|
4
|
Palombieri A, Sarchese V, Giordano MV, Fruci P, Crisi PE, Aste G, Bongiovanni L, Rinaldi V, Sposato A, Camero M, Lanave G, Martella V, Marsilio F, Di Martino B, Di Profio F. Detection and Characterization of Feline Calicivirus Associated with Paw and Mouth Disease. Animals (Basel) 2022; 13:ani13010065. [PMID: 36611675 PMCID: PMC9818015 DOI: 10.3390/ani13010065] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/26/2022] [Revised: 12/15/2022] [Accepted: 12/21/2022] [Indexed: 12/28/2022] Open
Abstract
Feline calicivirus (FCV) infection in cats can led to several diverse clinical presentations, ranging from mild upper respiratory signs to virulent systemic disease. Herein, we report a paw and mouth disease case in a 7-year-old household cat due to an FCV infection. An asymptomatic cat living in the same household was also infected with FCV. Clinical and pathological investigations were combined with the molecular and phenotypical characterization of the FCV strains. The RNA of the FCV was detected using qualitative and quantitative reverse transcription (RT)-PCR assays, and FCV antigen was confirmed by immunohistochemistry. After the whole genome analysis, the strains detected in the two cats appeared to be genetically diverse from FCVs previously detected in association with paw and mouth disease and with virulent systemic disease. Interestingly, the isolates obtained in this study were resistant to low pH conditions and slightly susceptible to bile salts, but they were susceptible to a trypsin treatment, revealing a phenotype pattern that is different from that which has been observed for respiratory FCVs.
Collapse
Affiliation(s)
- Andrea Palombieri
- Department of Veterinary Medicine, Università degli Studi di Teramo, 64100 Teramo, Italy
| | - Vittorio Sarchese
- Department of Veterinary Medicine, Università degli Studi di Teramo, 64100 Teramo, Italy
| | | | - Paola Fruci
- Department of Veterinary Medicine, Università degli Studi di Teramo, 64100 Teramo, Italy
| | - Paolo Emidio Crisi
- Department of Veterinary Medicine, Università degli Studi di Teramo, 64100 Teramo, Italy
| | - Giovanni Aste
- Department of Veterinary Medicine, Università degli Studi di Teramo, 64100 Teramo, Italy
| | - Laura Bongiovanni
- Department of Veterinary Medicine, Università degli Studi di Teramo, 64100 Teramo, Italy
- Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, 3584 Utrecht, The Netherlands
| | - Valentina Rinaldi
- Department of Veterinary Medicine, Università degli Studi di Teramo, 64100 Teramo, Italy
| | - Alessio Sposato
- Department of Veterinary Medicine, Università Aldo Moro di Bari, 70121 Bari, Italy
| | - Michele Camero
- Department of Veterinary Medicine, Università Aldo Moro di Bari, 70121 Bari, Italy
| | - Gianvito Lanave
- Department of Veterinary Medicine, Università Aldo Moro di Bari, 70121 Bari, Italy
| | - Vito Martella
- Department of Veterinary Medicine, Università Aldo Moro di Bari, 70121 Bari, Italy
| | - Fulvio Marsilio
- Department of Veterinary Medicine, Università degli Studi di Teramo, 64100 Teramo, Italy
| | - Barbara Di Martino
- Department of Veterinary Medicine, Università degli Studi di Teramo, 64100 Teramo, Italy
| | - Federica Di Profio
- Department of Veterinary Medicine, Università degli Studi di Teramo, 64100 Teramo, Italy
- Correspondence: ; Tel.: +39-0861-266845
| |
Collapse
|
5
|
Meli ML, Spiri AM, Zwicklbauer K, Krentz D, Felten S, Bergmann M, Dorsch R, Matiasek K, Alberer M, Kolberg L, von Both U, Hartmann K, Hofmann-Lehmann R. Fecal Feline Coronavirus RNA Shedding and Spike Gene Mutations in Cats with Feline Infectious Peritonitis Treated with GS-441524. Viruses 2022; 14:v14051069. [PMID: 35632813 PMCID: PMC9147249 DOI: 10.3390/v14051069] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2022] [Revised: 05/08/2022] [Accepted: 05/13/2022] [Indexed: 02/04/2023] Open
Abstract
As previously demonstrated by our research group, the oral multicomponent drug Xraphconn® containing GS-441524 was effective at curing otherwise fatal feline infectious peritonitis (FIP) in 18 feline coronavirus (FCoV)-infected cats. The aims of the current study were to investigate, using samples from the same animals as in the previous study, (1) the effect of treatment on fecal viral RNA shedding; (2) the presence of spike gene mutations in different body compartments of these cats; and (3) viral RNA shedding, presence of spike gene mutations, and anti-FCoV antibody titers in samples of 12 companion cats cohabitating with the treated cats. Eleven of the eighteen treated FIP cats (61%) were shedding FCoV RNA in feces within the first three days after treatment initiation, but all of them tested negative by day 6. In one of these cats, fecal shedding reoccurred on day 83. Two cats initially negative in feces were transiently positive 1–4 weeks into the study. The remaining five cats never shed FCoV. Viral RNA loads in feces decreased with time comparable with those in blood and effusion. Specific spike gene mutations linked to systemic FCoV spread were consistently found in blood and effusion from treated FIP cats, but not in feces from treated or companion cats. A new mutation that led to a not yet described amino acid change was identified, indicating that further mutations may be involved in the development of FIP. Eight of the twelve companion cats shed FCoV in feces. All but one of the twelve companion cats had anti-FCoV antibodies. Oral treatment with GS-441524 effectively decreased viral RNA loads in feces, blood, and effusion in cats with FIP. Nonetheless, re-shedding can most likely occur if cats are re-exposed to FCoV by their companion cats.
Collapse
Affiliation(s)
- Marina L. Meli
- Clinical Laboratory, Department of Clinical Diagnostics and Services, Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, CH-8057 Zurich, Switzerland; (A.M.S.); (R.H.-L.)
- Correspondence:
| | - Andrea M. Spiri
- Clinical Laboratory, Department of Clinical Diagnostics and Services, Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, CH-8057 Zurich, Switzerland; (A.M.S.); (R.H.-L.)
| | - Katharina Zwicklbauer
- Clinic of Small Animal Medicine, Centre for Clinical Veterinary Medicine, LMU Munich, D-80539 Munich, Germany; (K.Z.); (D.K.); (S.F.); (M.B.); (R.D.); (K.H.)
| | - Daniela Krentz
- Clinic of Small Animal Medicine, Centre for Clinical Veterinary Medicine, LMU Munich, D-80539 Munich, Germany; (K.Z.); (D.K.); (S.F.); (M.B.); (R.D.); (K.H.)
| | - Sandra Felten
- Clinic of Small Animal Medicine, Centre for Clinical Veterinary Medicine, LMU Munich, D-80539 Munich, Germany; (K.Z.); (D.K.); (S.F.); (M.B.); (R.D.); (K.H.)
| | - Michèle Bergmann
- Clinic of Small Animal Medicine, Centre for Clinical Veterinary Medicine, LMU Munich, D-80539 Munich, Germany; (K.Z.); (D.K.); (S.F.); (M.B.); (R.D.); (K.H.)
| | - Roswitha Dorsch
- Clinic of Small Animal Medicine, Centre for Clinical Veterinary Medicine, LMU Munich, D-80539 Munich, Germany; (K.Z.); (D.K.); (S.F.); (M.B.); (R.D.); (K.H.)
| | - Kaspar Matiasek
- Section of Clinical & Comparative Neuropathology, Institute of Veterinary Pathology, Centre for Clinical Veterinary Medicine, LMU Munich, D-80539 Munich, Germany;
| | - Martin Alberer
- Division of Paediatric Infectious Diseases, Dr. von Hauner Children’s Hospital, University Hospital, LMU-Munich, D-80337 Munich, Germany; (M.A.); (L.K.); (U.v.B.)
| | - Laura Kolberg
- Division of Paediatric Infectious Diseases, Dr. von Hauner Children’s Hospital, University Hospital, LMU-Munich, D-80337 Munich, Germany; (M.A.); (L.K.); (U.v.B.)
| | - Ulrich von Both
- Division of Paediatric Infectious Diseases, Dr. von Hauner Children’s Hospital, University Hospital, LMU-Munich, D-80337 Munich, Germany; (M.A.); (L.K.); (U.v.B.)
- German Center for Infection Research (DZIF), Partner Site Munich, D-80337 Munich, Germany
| | - Katrin Hartmann
- Clinic of Small Animal Medicine, Centre for Clinical Veterinary Medicine, LMU Munich, D-80539 Munich, Germany; (K.Z.); (D.K.); (S.F.); (M.B.); (R.D.); (K.H.)
| | - Regina Hofmann-Lehmann
- Clinical Laboratory, Department of Clinical Diagnostics and Services, Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, CH-8057 Zurich, Switzerland; (A.M.S.); (R.H.-L.)
| |
Collapse
|
6
|
Krentz D, Zenger K, Alberer M, Felten S, Bergmann M, Dorsch R, Matiasek K, Kolberg L, Hofmann-Lehmann R, Meli ML, Spiri AM, Horak J, Weber S, Holicki CM, Groschup MH, Zablotski Y, Lescrinier E, Koletzko B, von Both U, Hartmann K. Curing Cats with Feline Infectious Peritonitis with an Oral Multi-Component Drug Containing GS-441524. Viruses 2021; 13:v13112228. [PMID: 34835034 PMCID: PMC8621566 DOI: 10.3390/v13112228] [Citation(s) in RCA: 32] [Impact Index Per Article: 10.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2021] [Revised: 10/28/2021] [Accepted: 11/01/2021] [Indexed: 12/26/2022] Open
Abstract
Feline infectious peritonitis (FIP) caused by feline coronavirus (FCoV) is a common dis-ease in cats, fatal if untreated, and no effective treatment is currently legally available. The aim of this study was to evaluate efficacy and toxicity of the multi-component drug Xraphconn® in vitro and as oral treatment in cats with spontaneous FIP by examining survival rate, development of clinical and laboratory parameters, viral loads, anti-FCoV antibodies, and adverse effects. Mass spectrometry and nuclear magnetic resonance identified GS-441524 as an active component of Xraphconn®. Eighteen cats with FIP were prospectively followed up while being treated orally for 84 days. Values of key parameters on each examination day were compared to values before treatment initiation using linear mixed-effect models. Xraphconn® displayed high virucidal activity in cell culture. All cats recovered with dramatic improvement of clinical and laboratory parameters and massive reduction in viral loads within the first few days of treatment without serious adverse effects. Oral treatment with Xraphconn® containing GS-441524 was highly effective for FIP without causing serious adverse effects. This drug is an excellent option for the oral treatment of FIP and should be trialed as potential effective treatment option for other severe coronavirus-associated diseases across species.
Collapse
Affiliation(s)
- Daniela Krentz
- Clinic of Small Animal Medicine, Centre for Clinical Veterinary Medicine, LMU Munich, 80539 Munich, Germany; (K.Z.); (S.F.); (M.B.); (R.D.); (Y.Z.); (K.H.)
- Correspondence:
| | - Katharina Zenger
- Clinic of Small Animal Medicine, Centre for Clinical Veterinary Medicine, LMU Munich, 80539 Munich, Germany; (K.Z.); (S.F.); (M.B.); (R.D.); (Y.Z.); (K.H.)
| | - Martin Alberer
- Division of Paediatric Infectious Diseases, Dr. von Hauner Children’s Hospital, University Hospital, LMU Munich, 80337 Munich, Germany; (M.A.); (L.K.); (U.v.B.)
| | - Sandra Felten
- Clinic of Small Animal Medicine, Centre for Clinical Veterinary Medicine, LMU Munich, 80539 Munich, Germany; (K.Z.); (S.F.); (M.B.); (R.D.); (Y.Z.); (K.H.)
| | - Michèle Bergmann
- Clinic of Small Animal Medicine, Centre for Clinical Veterinary Medicine, LMU Munich, 80539 Munich, Germany; (K.Z.); (S.F.); (M.B.); (R.D.); (Y.Z.); (K.H.)
| | - Roswitha Dorsch
- Clinic of Small Animal Medicine, Centre for Clinical Veterinary Medicine, LMU Munich, 80539 Munich, Germany; (K.Z.); (S.F.); (M.B.); (R.D.); (Y.Z.); (K.H.)
| | - Kaspar Matiasek
- Section of Clinical and Comparative Neuropathology, Institute of Veterinary Pathology, Centre for Clinical Veterinary Medicine, LMU Munich, 80539 Munich, Germany;
| | - Laura Kolberg
- Division of Paediatric Infectious Diseases, Dr. von Hauner Children’s Hospital, University Hospital, LMU Munich, 80337 Munich, Germany; (M.A.); (L.K.); (U.v.B.)
| | - Regina Hofmann-Lehmann
- Clinical Laboratory, Department of Clinical Diagnostics and Services, and Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, CH-8057 Zurich, Switzerland; (R.H.-L.); (M.L.M.); (A.M.S.)
| | - Marina L. Meli
- Clinical Laboratory, Department of Clinical Diagnostics and Services, and Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, CH-8057 Zurich, Switzerland; (R.H.-L.); (M.L.M.); (A.M.S.)
| | - Andrea M. Spiri
- Clinical Laboratory, Department of Clinical Diagnostics and Services, and Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, CH-8057 Zurich, Switzerland; (R.H.-L.); (M.L.M.); (A.M.S.)
| | - Jeannie Horak
- Department Paediatrics, Division Metabolic and Nutritional Medicine, Dr. von Hauner Children’s Hospital, University Hospital, LMU Munich, 80337 Munich, Germany; (J.H.); (B.K.)
| | - Saskia Weber
- Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, 17493 Greifswald, Germany; (S.W.); (C.M.H.); (M.H.G.)
| | - Cora M. Holicki
- Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, 17493 Greifswald, Germany; (S.W.); (C.M.H.); (M.H.G.)
| | - Martin H. Groschup
- Institute of Novel and Emerging Infectious Diseases, Friedrich-Loeffler-Institut, Greifswald-Insel Riems, 17493 Greifswald, Germany; (S.W.); (C.M.H.); (M.H.G.)
- German Center for Infection Research (DZIF), Partner Site Hamburg-Luebeck-Borstel-Riems, Greifswald-Insel Riems, 17493 Greifswald, Germany
| | - Yury Zablotski
- Clinic of Small Animal Medicine, Centre for Clinical Veterinary Medicine, LMU Munich, 80539 Munich, Germany; (K.Z.); (S.F.); (M.B.); (R.D.); (Y.Z.); (K.H.)
| | - Eveline Lescrinier
- Medicinal Chemistry, KU Leuven, Rega Institute for Medical Research, 3000 Leuven, Belgium;
| | - Berthold Koletzko
- Department Paediatrics, Division Metabolic and Nutritional Medicine, Dr. von Hauner Children’s Hospital, University Hospital, LMU Munich, 80337 Munich, Germany; (J.H.); (B.K.)
| | - Ulrich von Both
- Division of Paediatric Infectious Diseases, Dr. von Hauner Children’s Hospital, University Hospital, LMU Munich, 80337 Munich, Germany; (M.A.); (L.K.); (U.v.B.)
- German Center for Infection Research (DZIF), Partner Site Munich, 80337 Munich, Germany
| | - Katrin Hartmann
- Clinic of Small Animal Medicine, Centre for Clinical Veterinary Medicine, LMU Munich, 80539 Munich, Germany; (K.Z.); (S.F.); (M.B.); (R.D.); (Y.Z.); (K.H.)
| |
Collapse
|
7
|
Spiri AM, Novacco M, Meli ML, Stirn M, Riond B, Fogle JE, Boretti FS, Herbert I, Hosie MJ, Hofmann-Lehmann R. Modified-Live Feline Calicivirus Vaccination Elicits Cellular Immunity against a Current Feline Calicivirus Field Strain in an Experimental Feline Challenge Study. Viruses 2021; 13:v13091736. [PMID: 34578316 PMCID: PMC8473420 DOI: 10.3390/v13091736] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2021] [Revised: 08/23/2021] [Accepted: 08/26/2021] [Indexed: 02/07/2023] Open
Abstract
Feline calicivirus (FCV) is a common cat virus associated with oral ulcerations and virulent-systemic disease. Efficacious FCV vaccines protect against severe disease but not against infection. The high genetic diversity of FCV poses a challenge in vaccine design. Protection against FCV has been related to humoral and cellular immunity; the latter has not been studied in detail. This study investigates the cellular and humoral immune response of specified pathogen-free (SPF) cats after modified-live FCV F9 vaccinations and two heterologous FCV challenges by the analysis of lymphocyte subsets, cytokine mRNA transcription levels, interferon (IFN)-γ release assays in peripheral blood mononuclear cells (PBMCs), anti-FCV antibodies, and neutralisation activity. Vaccinated cats developed a Th1 cytokine response after vaccination. Vaccination resulted in antibodies with neutralising activity against the vaccine but not the challenge viruses. Remarkably, IFN-γ-releasing PBMCs were detected in vaccinated cats upon stimulation with the vaccine strain and the first heterologous FCV challenge strain. After the first experimental infection, the mRNA transcription levels of perforin, granzyme B, INF-γ, and antiviral factor MX1 and the number of IFN-γ-releasing PBMCs when stimulated with the first challenge virus were higher in vaccinated cats compared to control cats. The first FCV challenge induced crossneutralising antibodies in all cats against the second challenge virus. Before the second challenge, vaccinated cats had a higher number of IFN-γ-releasing PBMCs when stimulated with the second challenge virus than control cats. After the second FCV challenge, there were less significant differences detected between the groups regarding lymphocyte subsets and cytokine mRNA transcription levels. In conclusion, modified-live FCV vaccination induced cellular but not humoral crossimmunity in SPF cats; innate immune mechanisms, secretory and membranolytic pathways, and IFN-γ-releasing PBMCs seem to be important in the host immune defence against FCV.
Collapse
Affiliation(s)
- Andrea M. Spiri
- Clinical Laboratory, Department of Clinical Diagnostics and Services, Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, CH-8057 Zurich, Switzerland; (M.N.); (M.L.M.); (M.S.); (B.R.); (R.H.-L.)
- Correspondence: ; Tel.: +41-44-635-83-78
| | - Marilisa Novacco
- Clinical Laboratory, Department of Clinical Diagnostics and Services, Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, CH-8057 Zurich, Switzerland; (M.N.); (M.L.M.); (M.S.); (B.R.); (R.H.-L.)
| | - Marina L. Meli
- Clinical Laboratory, Department of Clinical Diagnostics and Services, Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, CH-8057 Zurich, Switzerland; (M.N.); (M.L.M.); (M.S.); (B.R.); (R.H.-L.)
| | - Martina Stirn
- Clinical Laboratory, Department of Clinical Diagnostics and Services, Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, CH-8057 Zurich, Switzerland; (M.N.); (M.L.M.); (M.S.); (B.R.); (R.H.-L.)
| | - Barbara Riond
- Clinical Laboratory, Department of Clinical Diagnostics and Services, Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, CH-8057 Zurich, Switzerland; (M.N.); (M.L.M.); (M.S.); (B.R.); (R.H.-L.)
| | - Jonathan E. Fogle
- Comparative Immunology Research Laboratory, College of Veterinary Medicine, North Carolina State University, Raleigh, NC 27695, USA;
| | - Felicitas S. Boretti
- Clinic for Small Animal Internal Medicine, Vetsuisse Faculty, University of Zurich, CH-8057 Zurich, Switzerland;
| | - Imogen Herbert
- Medical Research Council-University of Glasgow, Centre for Virus Research, Glasgow G61 1QH, UK; (I.H.); (M.J.H.)
| | - Margaret J. Hosie
- Medical Research Council-University of Glasgow, Centre for Virus Research, Glasgow G61 1QH, UK; (I.H.); (M.J.H.)
| | - Regina Hofmann-Lehmann
- Clinical Laboratory, Department of Clinical Diagnostics and Services, Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, CH-8057 Zurich, Switzerland; (M.N.); (M.L.M.); (M.S.); (B.R.); (R.H.-L.)
| |
Collapse
|
8
|
First Description of Sarcoptic Mange in a Free-Ranging European Wildcat ( Felis silvestris silvestris) from Spain. Animals (Basel) 2021; 11:ani11092494. [PMID: 34573459 PMCID: PMC8466406 DOI: 10.3390/ani11092494] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2021] [Revised: 08/15/2021] [Accepted: 08/23/2021] [Indexed: 12/03/2022] Open
Abstract
Simple Summary Sarcoptic mange caused by the mite Sarcoptes scabiei is a worldwide-distributed skin infestation with a wide range of hosts, among them several species within the Felidae family. Sarcoptes scabiei was diagnosed in a dead adult female European wildcat (Felis silvestris silvestris) from Spain. This is the first description of Sarcoptes scabiei in a European wildcat. Since this is a species of conservation concern due to its critical demography in the southernmost population of the Iberian Peninsula, the impacts of infectious diseases, including sarcoptic mange, should be considered during disease surveillance programs of the species’ populations. Abstract Sarcoptic mange caused by the mite Sarcoptes scabiei is a worldwide-distributed skin infestation with a wide range of hosts, among them several species within the Felidae family. Sarcoptes scabiei was diagnosed in a dead adult female European wildcat (Felis silvestris silvestris) from Spain, based on histological evaluation of skin biopsies and identification of the arthropod from skin scrapings and molecular methods. This is the first description of Sarcoptes scabiei in a European wildcat. Due to its critical demography in the southernmost population of the Iberian Peninsula, the impacts of infectious diseases, including sarcoptic mange, as a new potential threat should be considered during disease surveillance programs of the species’ populations.
Collapse
|
9
|
Cottingham E, Johnstone T, Hartley CA, Devlin JM. Use of feline herpesvirus as a vaccine vector offers alternative applications for feline health. Vet Microbiol 2021; 261:109210. [PMID: 34416538 DOI: 10.1016/j.vetmic.2021.109210] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/05/2021] [Accepted: 08/15/2021] [Indexed: 12/26/2022]
Abstract
Herpesviruses are attractive vaccine vector candidates due to their large double stranded DNA genome and latency characteristics. Within the scope of veterinary vaccines, herpesvirus-vectored vaccines have been well studied and commercially available vectored vaccines are used to help prevent diseases in different animal species. Felid alphaherpesvirus 1 (FHV-1) has been characterised as a vector candidate to protect against a range of feline pathogens. In this review we highlight the methods used to construct FHV-1 based vaccines and their outcomes, while also proposing alternative uses for FHV-1 as a viral vector.
Collapse
Affiliation(s)
- Ellen Cottingham
- The Asia Pacific Centre for Animal Health, Melbourne Veterinary School, The University of Melbourne, Parkville, Victoria, 3010, Australia.
| | - Thurid Johnstone
- U-Vet Animal Hospital, Faculty of Veterinary and Agricultural Sciences, University of Melbourne, Werribee, Victoria, 3030, Australia
| | - Carol A Hartley
- The Asia Pacific Centre for Animal Health, Melbourne Veterinary School, The University of Melbourne, Parkville, Victoria, 3010, Australia
| | - Joanne M Devlin
- The Asia Pacific Centre for Animal Health, Melbourne Veterinary School, The University of Melbourne, Parkville, Victoria, 3010, Australia
| |
Collapse
|
10
|
Spiri AM, Riond B, Stirn M, Novacco M, Meli ML, Boretti FS, Herbert I, Hosie MJ, Hofmann-Lehmann R. Modified-Live Feline Calicivirus Vaccination Reduces Viral RNA Loads, Duration of RNAemia, and the Severity of Clinical Signs after Heterologous Feline Calicivirus Challenge. Viruses 2021; 13:1505. [PMID: 34452370 PMCID: PMC8402717 DOI: 10.3390/v13081505] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/14/2021] [Revised: 07/21/2021] [Accepted: 07/27/2021] [Indexed: 02/06/2023] Open
Abstract
Feline calicivirus (FCV) is a common cat virus causing clinical signs such as oral ulcerations, fever, reduced general condition, pneumonia, limping and occasionally virulent-systemic disease. Efficacious FCV vaccines protect against severe disease but not against infection. FCV is a highly mutagenic RNA virus whose high genetic diversity poses a challenge in vaccine design. The use of only one modified-live FCV strain over several decades might have driven the viral evolution towards more vaccine-resistant variants. The present study investigated the clinical signs, duration, and amount of FCV shedding, RNAemia, haematological changes and acute phase protein reaction in SPF cats after subcutaneous modified-live single strain FCV vaccination or placebo injection and two subsequent oronasal heterologous FCV challenge infections with two different field strains. Neither clinical signs nor FCV shedding from the oropharynx and FCV RNAemia were detected after vaccination. After the first experimental infection, vaccinated cats had significantly lower clinical scores, less increased body temperature and lower acute phase protein levels than control cats. The viral RNA loads from the oropharynx and duration and amount of RNAemia were significantly lower in the vaccinated animals. No clinical signs were observed in any of the cats after the second experimental infection. In conclusion, FCV vaccination was beneficial for protecting cats from severe clinical signs, reducing viral loads and inflammation after FCV challenge.
Collapse
Affiliation(s)
- Andrea M. Spiri
- Clinical Laboratory, Department of Clinical Diagnostics and Services and Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland; (B.R.); (M.S.); (M.N.); (M.L.M.); (R.H.-L.)
| | - Barbara Riond
- Clinical Laboratory, Department of Clinical Diagnostics and Services and Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland; (B.R.); (M.S.); (M.N.); (M.L.M.); (R.H.-L.)
| | - Martina Stirn
- Clinical Laboratory, Department of Clinical Diagnostics and Services and Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland; (B.R.); (M.S.); (M.N.); (M.L.M.); (R.H.-L.)
| | - Marilisa Novacco
- Clinical Laboratory, Department of Clinical Diagnostics and Services and Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland; (B.R.); (M.S.); (M.N.); (M.L.M.); (R.H.-L.)
| | - Marina L. Meli
- Clinical Laboratory, Department of Clinical Diagnostics and Services and Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland; (B.R.); (M.S.); (M.N.); (M.L.M.); (R.H.-L.)
| | - Felicitas S. Boretti
- Clinic for Small Animal Internal Medicine, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland;
| | - Imogen Herbert
- Medical Research Council-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK; (I.H.); (M.J.H.)
| | - Margaret J. Hosie
- Medical Research Council-University of Glasgow Centre for Virus Research, Glasgow G61 1QH, UK; (I.H.); (M.J.H.)
| | - Regina Hofmann-Lehmann
- Clinical Laboratory, Department of Clinical Diagnostics and Services and Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, 8057 Zurich, Switzerland; (B.R.); (M.S.); (M.N.); (M.L.M.); (R.H.-L.)
| |
Collapse
|
11
|
Anti-SU Antibody Responses in Client-Owned Cats Following Vaccination against Feline Leukaemia Virus with Two Inactivated Whole-Virus Vaccines (Fel-O-Vax ® Lv-K and Fel-O-Vax ® 5). Viruses 2021; 13:v13020240. [PMID: 33546485 PMCID: PMC7913631 DOI: 10.3390/v13020240] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/29/2020] [Revised: 01/29/2021] [Accepted: 02/02/2021] [Indexed: 12/16/2022] Open
Abstract
A field study undertaken in Australia compared the antibody responses induced in client-owned cats that had been vaccinated using two inactivated whole feline leukaemia virus (FeLV) vaccines, the monovalent vaccine Fel-O-Vax® Lv-K and the polyvalent vaccine Fel-O-Vax® 5. Serum samples from 428 FeLV-uninfected cats (118 FeLV-vaccinated and 310 FeLV-unvaccinated) were tested for anti-FeLV neutralising antibodies (NAb) using a live virus neutralisation assay to identify 378 FeLV-unexposed (NAb-negative) and 50 FeLV-exposed (NAb-positive; abortive infections) cats, following by anti-surface unit (SU) FeLV-A and FeLV-B antibody ELISA testing. An additional 42 FeLV-infected cats (28 presumptively regressively infected, 14 presumptively progressively infected) were also tested for anti-SU antibodies. NAb-positive cats displayed significantly higher anti-SU antibody ELISA responses compared to NAb-negative cats (p < 0.001). FeLV-unexposed cats (NAb-negative) that had been vaccinated less than 18 months after a previous FeLV vaccination using the monovalent vaccine (Fel-O-Vax® Lv-K) displayed higher anti-SU antibody ELISA responses than a comparable group vaccinated with the polyvalent vaccine (Fel-O-Vax® 5) (p < 0.001 for both anti-FeLV-A and FeLV-B SU antibody responses). This difference in anti-SU antibody responses between cats vaccinated with the monovalent or polyvalent vaccine, however, was not observed in cats that had been naturally exposed to FeLV (NAb-positive) (p = 0.33). It was postulated that vaccination with Fel-O-Vax® 5 primed the humoral response prior to FeLV exposure, such that antibody production increased when the animal was challenged, while vaccination with Fel-O-Vax® Lv-K induced an immediate preparatory antibody response that did not quantitatively increase after FeLV exposure. These results raise questions about the comparable vaccine efficacy of the different FeLV vaccine formulations and correlates of protection.
Collapse
|
12
|
Correlation of Feline Coronavirus Shedding in Feces with Coronavirus Antibody Titer. Pathogens 2020; 9:pathogens9080598. [PMID: 32707796 PMCID: PMC7459802 DOI: 10.3390/pathogens9080598] [Citation(s) in RCA: 24] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2020] [Revised: 07/12/2020] [Accepted: 07/14/2020] [Indexed: 12/21/2022] Open
Abstract
BACKGROUND Feline coronavirus (FCoV) infection is ubiquitous in multi-cat households. Responsible for the continuous presence are cats that are chronically shedding a high load of FCoV. The aim of the study was to determine a possible correlation between FCoV antibody titer and frequency and load of fecal FCoV shedding in cats from catteries. METHODS Four fecal samples from each of 82 cats originating from 19 German catteries were examined for FCoV viral loads by quantitative reverse transcriptase polymerase chain reaction (RT-qPCR). Additionally, antibody titers were determined by an immunofluorescence assay. RESULTS Cats with antibodies were more likely to be FCoV shedders than non-shedders, and there was a weak positive correlation between antibody titer and mean fecal virus load (Spearman r = 0.2984; p = 0.0072). Antibody titers were significantly higher if cats shed FCoV more frequently throughout the study period (p = 0.0063). When analyzing only FCoV shedders, cats that were RT-qPCR-positive in all four samples had significantly higher antibody titers (p = 0.0014) and significantly higher mean fecal virus loads (p = 0.0475) than cats that were RT-qPCR-positive in only one, two, or three samples. CONCLUSIONS The cats' antibody titers correlate with the likelihood and frequency of FCoV shedding and fecal virus load. Chronic shedders have higher antibody titers and shed more virus. This knowledge is important for the management of FCoV infections in multi-cat environments, but the results indicate that antibody measurement cannot replace fecal RT-qPCR.
Collapse
|
13
|
Ferri F, Porporato F, Rossi F, Enache D, Callegari C, Gerardi G, Coppola LM, Contiero B, Crinò C, Kohan NR, Meli ML, Lutz H, Hofmann-Lehmann R, Zini E. Treatment with Class A CpG Oligodeoxynucleotides in Cats with Naturally Occurring Feline Parvovirus Infection: A Prospective Study. Viruses 2020; 12:v12060640. [PMID: 32545689 PMCID: PMC7354499 DOI: 10.3390/v12060640] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2020] [Revised: 06/07/2020] [Accepted: 06/09/2020] [Indexed: 01/29/2023] Open
Abstract
Feline parvovirus (FPV) causes severe gastroenteritis and leukopenia in cats; the outcome is poor. Information regarding specific treatments is lacking. Class A CpG oligodeoxynucleotides (CpG-A) are short single-stranded DNAs, stimulating type I interferon production. In cats, CpG-A induced an antiviral response in vivo and inhibited FPV replication in vitro. The aim was to prospectively investigate the effects of CpG-A on survival, clinical score, hematological findings, antiviral response (cytokines), viremia, and fecal shedding (real-time qPCR) in cats naturally infected with FPV. Forty-two FPV-infected cats were randomized to receive 100 µg/kg of CpG-A (n = 22) or placebo (n = 20) subcutaneously, on admission and after 48 h. Blood and fecal samples were collected on admission, after 1, 3, and 7 days. All 22 cats showed short duration pain during CpG-A injections. The survival rate, clinical score, leukocyte and erythrocyte counts, viremia, and fecal shedding at any time-point did not differ between cats treated with CpG-A (50%) and placebo (40%). Antiviral myxovirus resistance (Mx) gene transcription increased in both groups from day 1 to 3 (p = 0.005). Antibodies against FPV on admission were associated with survival in cats (p = 0.002). In conclusion, CpG-A treatment did not improve the outcome in cats with FPV infection. FPV infection produced an antiviral response.
Collapse
Affiliation(s)
- Filippo Ferri
- AniCura Istituto Veterinario di Novara, Strada Provinciale 9, 28060 Granozzo con Monticello (NO), Italy; (F.P.); (F.R.); (D.E.); (C.C.); (E.Z.)
- Correspondence: ; Tel.: +39-0321-4600155
| | - Federico Porporato
- AniCura Istituto Veterinario di Novara, Strada Provinciale 9, 28060 Granozzo con Monticello (NO), Italy; (F.P.); (F.R.); (D.E.); (C.C.); (E.Z.)
| | - Francesco Rossi
- AniCura Istituto Veterinario di Novara, Strada Provinciale 9, 28060 Granozzo con Monticello (NO), Italy; (F.P.); (F.R.); (D.E.); (C.C.); (E.Z.)
| | - Daniela Enache
- AniCura Istituto Veterinario di Novara, Strada Provinciale 9, 28060 Granozzo con Monticello (NO), Italy; (F.P.); (F.R.); (D.E.); (C.C.); (E.Z.)
| | - Carolina Callegari
- AniCura Istituto Veterinario di Novara, Strada Provinciale 9, 28060 Granozzo con Monticello (NO), Italy; (F.P.); (F.R.); (D.E.); (C.C.); (E.Z.)
| | - Gabriele Gerardi
- Department of Animal Medicine, Production and Health, University of Padova, viale dell’Università 16, 35020 Legnaro (PD), Italy; (G.G.); (L.M.C.); (B.C.)
| | - Luigi M. Coppola
- Department of Animal Medicine, Production and Health, University of Padova, viale dell’Università 16, 35020 Legnaro (PD), Italy; (G.G.); (L.M.C.); (B.C.)
| | - Barbara Contiero
- Department of Animal Medicine, Production and Health, University of Padova, viale dell’Università 16, 35020 Legnaro (PD), Italy; (G.G.); (L.M.C.); (B.C.)
| | - Chiara Crinò
- The Ralph Veterinary Referral Centre, Fourth Avenue, Globe Business Park, Marlow SL7 1YG, UK;
| | - Neda Ranjbar Kohan
- Clinical Laboratory, Department of Clinical Diagnostics and Services, and Center for Clinical studies, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, 8057 Zurich, Switzerland; (N.R.K.); (M.L.M.); (H.L.); (R.H.-L.)
| | - Marina L. Meli
- Clinical Laboratory, Department of Clinical Diagnostics and Services, and Center for Clinical studies, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, 8057 Zurich, Switzerland; (N.R.K.); (M.L.M.); (H.L.); (R.H.-L.)
| | - Hans Lutz
- Clinical Laboratory, Department of Clinical Diagnostics and Services, and Center for Clinical studies, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, 8057 Zurich, Switzerland; (N.R.K.); (M.L.M.); (H.L.); (R.H.-L.)
| | - Regina Hofmann-Lehmann
- Clinical Laboratory, Department of Clinical Diagnostics and Services, and Center for Clinical studies, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, 8057 Zurich, Switzerland; (N.R.K.); (M.L.M.); (H.L.); (R.H.-L.)
| | - Eric Zini
- AniCura Istituto Veterinario di Novara, Strada Provinciale 9, 28060 Granozzo con Monticello (NO), Italy; (F.P.); (F.R.); (D.E.); (C.C.); (E.Z.)
- Department of Animal Medicine, Production and Health, University of Padova, viale dell’Università 16, 35020 Legnaro (PD), Italy; (G.G.); (L.M.C.); (B.C.)
- Clinic for Small Animal Internal Medicine, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, 8057 Zurich, Switzerland
| |
Collapse
|
14
|
Meli ML, Berger A, Willi B, Spiri AM, Riond B, Hofmann-Lehmann R. Molecular detection of feline calicivirus in clinical samples: A study comparing its detection by RT-qPCR directly from swabs and after virus isolation. J Virol Methods 2017; 251:54-60. [PMID: 28986291 DOI: 10.1016/j.jviromet.2017.10.001] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2016] [Revised: 08/31/2017] [Accepted: 10/01/2017] [Indexed: 10/18/2022]
Abstract
Feline caliciviruses (FCVs) are non-enveloped RNA viruses that exhibit high genetic variation. Two reverse transcription quantitative polymerase chain reaction (RT-qPCR) FCV assays (S1 and S2) were evaluated using samples from 300 field cats. The direct detection of FCV in swabs and after propagation in cell culture, as well as the influence of storage conditions, was assessed. FCV-RNA detectability on dry swabs was similar after storage at either 4°C or -20°C, but viral burdens were maintained for a longer time period when viral transport medium was used. A total of 97 (32%) samples was considered FCV PCR-positive. Of these, 81% and 77% tested positive directly from swabs using S1 and S2, respectively; 84% and 81% tested positive after enrichment in cell culture, respectively. Combined detection by RT-PCR directly from swabs and after VI was most sensitive (up to 96%). Neither of the methods alone were able to detect all FCV-positive samples. In conclusion, clinical samples should be collected in viral transport medium, stored at ≤4°C and processed as soon as possible. The combination of cell culture with RT-qPCR or detection directly from swabs using a combination of different RT-qPCR assays is recommended to reach a high sensitivity of FCV detection.
Collapse
Affiliation(s)
- Marina L Meli
- Clinical Laboratory, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland; Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
| | - Alice Berger
- Clinical Laboratory, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland; Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
| | - Barbara Willi
- Clinical Laboratory, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland; Clinic for Small Animal Internal Medicine, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
| | - Andrea M Spiri
- Clinical Laboratory, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland; Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
| | - Barbara Riond
- Clinical Laboratory, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
| | - Regina Hofmann-Lehmann
- Clinical Laboratory, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland; Center for Clinical Studies, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
| |
Collapse
|
15
|
Englert T, Lutz H, Sauter-Louis C, Hartmann K. Survey of the feline leukemia virus infection status of cats in Southern Germany. J Feline Med Surg 2012; 14:392-8. [DOI: 10.1177/1098612x12440531] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Most studies that investigate the prevalence of infections with feline leukemia virus (FeLV) are based on the detection of p27 antigen in blood, but they do not detect proviral DNA to identify the prevalence of regressive FeLV infections. The aim of the present study was to assess the prevalence and status of FeLV infection in cats in Southern Germany. P27 antigen enzyme-linked immunosorbent assay (ELISA), anti-p45 antibody ELISA, DNA polymerase chain reaction (PCR) of blood and RNA PCR of saliva were performed. Nine out of 495 cats were progressively (persistently) infected (1.8%) and six were regressively (latently) infected (1.2%). Cats with regressive infections are defined as cats that have been able to overcome antigenemia but provirus can be detected by PCR. Twenty-two unvaccinated cats likely had abortive infections (regressor cats), testing FeLV antigen- and provirus-negative but anti-p45 antibody-positive. Most of the FeLV-vaccinated cats did not have anti-FeLV antibodies. Both progressive, as well as regressive infections seem to be rare in Germany today.
Collapse
Affiliation(s)
| | - Hans Lutz
- Clinical Laboratory, Vetsuisse Faculty, University of Zurich, Winterthurerstrasse 260, 8057 Zurich, Switzerland
| | | | | |
Collapse
|
16
|
Filoni C, Catão-Dias JL, Cattori V, Willi B, Meli ML, Corrêa SHR, Marques MC, Adania CH, Silva JCR, Marvulo MFV, Neto JSF, Durigon EL, de Carvalho VM, Coutinho SD, Lutz H, Hofmann-Lehmann R. Surveillance using serological and molecular methods for the detection of infectious agents in captive Brazilian neotropic and exotic felids. J Vet Diagn Invest 2011; 24:166-73. [DOI: 10.1177/1040638711407684] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
The aim of the current study was to investigate the exposure of captive wild felids to various infectious pathogens using serological and molecular methods. One hundred and fifty-nine neotropic felids and 51 exotic felids from 28 captive settings in Brazil were tested. While antibodies against Feline parvovirus and Feline coronavirus (FCoV), Feline calicivirus and Bartonella spp. were frequently detected by serologic tests, antibodies against Felid herpesvirus 1 or infection with hemotropic mycoplasmas were less prevalent. Serologic evidence of exposure to Ehrlichia spp., Feline immunodeficiency virus, and Feline leukemia virus (FeLV) was detected rarely, and infections with FeLV, Ehrlichia spp., and Cytauxzoon spp. were found infrequently. The detected Bartonella sequence was molecularly similar to B. koehlerae and B. henselae; for Cytauxzoon, the sequence resembled those from domestic cats. No Anaplasma phagocytophilum and Theileria spp. infections were detected. The positive test results varied significantly among different facilities and species. Additionally, FCoV seropositivity was more prevalent in captivity than in free-ranging populations. Results suggest that testing is appropriate prior to relocation of felids.
Collapse
Affiliation(s)
- Claudia Filoni
- Department of Pathology, Faculty of Veterinary Medicine and Zootechny, University of São Paulo, São Paulo, SP (Filoni, Catão-Dias)
- Brazilian Institute for Conservation Medicine–TRÍADE, São Paulo, SP (Filoni, Silva, Marvulo)
- Laboratory of Molecular and Cellular Biology, Veterinary Medicine, Paulista University, São Paulo, SP (Filoni, de Carvalho, Coutinho)
- São Paulo Zoological Park Foundation, São Paulo, SP (Catão-Dias, Corrêa, Marques)
- Mata Ciliar Association, Jundiaí, SP (Adania)
| | - José Luiz Catão-Dias
- Department of Pathology, Faculty of Veterinary Medicine and Zootechny, University of São Paulo, São Paulo, SP (Filoni, Catão-Dias)
- Brazilian Institute for Conservation Medicine–TRÍADE, São Paulo, SP (Filoni, Silva, Marvulo)
- Laboratory of Molecular and Cellular Biology, Veterinary Medicine, Paulista University, São Paulo, SP (Filoni, de Carvalho, Coutinho)
- São Paulo Zoological Park Foundation, São Paulo, SP (Catão-Dias, Corrêa, Marques)
- Mata Ciliar Association, Jundiaí, SP (Adania)
| | - Valentino Cattori
- Department of Pathology, Faculty of Veterinary Medicine and Zootechny, University of São Paulo, São Paulo, SP (Filoni, Catão-Dias)
- Brazilian Institute for Conservation Medicine–TRÍADE, São Paulo, SP (Filoni, Silva, Marvulo)
- Laboratory of Molecular and Cellular Biology, Veterinary Medicine, Paulista University, São Paulo, SP (Filoni, de Carvalho, Coutinho)
- São Paulo Zoological Park Foundation, São Paulo, SP (Catão-Dias, Corrêa, Marques)
- Mata Ciliar Association, Jundiaí, SP (Adania)
| | - Barbara Willi
- Department of Pathology, Faculty of Veterinary Medicine and Zootechny, University of São Paulo, São Paulo, SP (Filoni, Catão-Dias)
- Brazilian Institute for Conservation Medicine–TRÍADE, São Paulo, SP (Filoni, Silva, Marvulo)
- Laboratory of Molecular and Cellular Biology, Veterinary Medicine, Paulista University, São Paulo, SP (Filoni, de Carvalho, Coutinho)
- São Paulo Zoological Park Foundation, São Paulo, SP (Catão-Dias, Corrêa, Marques)
- Mata Ciliar Association, Jundiaí, SP (Adania)
| | - Marina L. Meli
- Department of Pathology, Faculty of Veterinary Medicine and Zootechny, University of São Paulo, São Paulo, SP (Filoni, Catão-Dias)
- Brazilian Institute for Conservation Medicine–TRÍADE, São Paulo, SP (Filoni, Silva, Marvulo)
- Laboratory of Molecular and Cellular Biology, Veterinary Medicine, Paulista University, São Paulo, SP (Filoni, de Carvalho, Coutinho)
- São Paulo Zoological Park Foundation, São Paulo, SP (Catão-Dias, Corrêa, Marques)
- Mata Ciliar Association, Jundiaí, SP (Adania)
| | - Sandra Helena Ramiro Corrêa
- Department of Pathology, Faculty of Veterinary Medicine and Zootechny, University of São Paulo, São Paulo, SP (Filoni, Catão-Dias)
- Brazilian Institute for Conservation Medicine–TRÍADE, São Paulo, SP (Filoni, Silva, Marvulo)
- Laboratory of Molecular and Cellular Biology, Veterinary Medicine, Paulista University, São Paulo, SP (Filoni, de Carvalho, Coutinho)
- São Paulo Zoological Park Foundation, São Paulo, SP (Catão-Dias, Corrêa, Marques)
- Mata Ciliar Association, Jundiaí, SP (Adania)
| | - Mara Cristina Marques
- Department of Pathology, Faculty of Veterinary Medicine and Zootechny, University of São Paulo, São Paulo, SP (Filoni, Catão-Dias)
- Brazilian Institute for Conservation Medicine–TRÍADE, São Paulo, SP (Filoni, Silva, Marvulo)
- Laboratory of Molecular and Cellular Biology, Veterinary Medicine, Paulista University, São Paulo, SP (Filoni, de Carvalho, Coutinho)
- São Paulo Zoological Park Foundation, São Paulo, SP (Catão-Dias, Corrêa, Marques)
- Mata Ciliar Association, Jundiaí, SP (Adania)
| | - Cristina Harumi Adania
- Department of Pathology, Faculty of Veterinary Medicine and Zootechny, University of São Paulo, São Paulo, SP (Filoni, Catão-Dias)
- Brazilian Institute for Conservation Medicine–TRÍADE, São Paulo, SP (Filoni, Silva, Marvulo)
- Laboratory of Molecular and Cellular Biology, Veterinary Medicine, Paulista University, São Paulo, SP (Filoni, de Carvalho, Coutinho)
- São Paulo Zoological Park Foundation, São Paulo, SP (Catão-Dias, Corrêa, Marques)
- Mata Ciliar Association, Jundiaí, SP (Adania)
| | - Jean Carlos Ramos Silva
- Department of Pathology, Faculty of Veterinary Medicine and Zootechny, University of São Paulo, São Paulo, SP (Filoni, Catão-Dias)
- Brazilian Institute for Conservation Medicine–TRÍADE, São Paulo, SP (Filoni, Silva, Marvulo)
- Laboratory of Molecular and Cellular Biology, Veterinary Medicine, Paulista University, São Paulo, SP (Filoni, de Carvalho, Coutinho)
- São Paulo Zoological Park Foundation, São Paulo, SP (Catão-Dias, Corrêa, Marques)
- Mata Ciliar Association, Jundiaí, SP (Adania)
| | - Maria Fernanda Vianna Marvulo
- Department of Pathology, Faculty of Veterinary Medicine and Zootechny, University of São Paulo, São Paulo, SP (Filoni, Catão-Dias)
- Brazilian Institute for Conservation Medicine–TRÍADE, São Paulo, SP (Filoni, Silva, Marvulo)
- Laboratory of Molecular and Cellular Biology, Veterinary Medicine, Paulista University, São Paulo, SP (Filoni, de Carvalho, Coutinho)
- São Paulo Zoological Park Foundation, São Paulo, SP (Catão-Dias, Corrêa, Marques)
- Mata Ciliar Association, Jundiaí, SP (Adania)
| | - José Soares Ferreira Neto
- Department of Pathology, Faculty of Veterinary Medicine and Zootechny, University of São Paulo, São Paulo, SP (Filoni, Catão-Dias)
- Brazilian Institute for Conservation Medicine–TRÍADE, São Paulo, SP (Filoni, Silva, Marvulo)
- Laboratory of Molecular and Cellular Biology, Veterinary Medicine, Paulista University, São Paulo, SP (Filoni, de Carvalho, Coutinho)
- São Paulo Zoological Park Foundation, São Paulo, SP (Catão-Dias, Corrêa, Marques)
- Mata Ciliar Association, Jundiaí, SP (Adania)
| | - Edison Luiz Durigon
- Department of Pathology, Faculty of Veterinary Medicine and Zootechny, University of São Paulo, São Paulo, SP (Filoni, Catão-Dias)
- Brazilian Institute for Conservation Medicine–TRÍADE, São Paulo, SP (Filoni, Silva, Marvulo)
- Laboratory of Molecular and Cellular Biology, Veterinary Medicine, Paulista University, São Paulo, SP (Filoni, de Carvalho, Coutinho)
- São Paulo Zoological Park Foundation, São Paulo, SP (Catão-Dias, Corrêa, Marques)
- Mata Ciliar Association, Jundiaí, SP (Adania)
| | - Vania Maria de Carvalho
- Department of Pathology, Faculty of Veterinary Medicine and Zootechny, University of São Paulo, São Paulo, SP (Filoni, Catão-Dias)
- Brazilian Institute for Conservation Medicine–TRÍADE, São Paulo, SP (Filoni, Silva, Marvulo)
- Laboratory of Molecular and Cellular Biology, Veterinary Medicine, Paulista University, São Paulo, SP (Filoni, de Carvalho, Coutinho)
- São Paulo Zoological Park Foundation, São Paulo, SP (Catão-Dias, Corrêa, Marques)
- Mata Ciliar Association, Jundiaí, SP (Adania)
| | - Selene Dall’Acqua Coutinho
- Department of Pathology, Faculty of Veterinary Medicine and Zootechny, University of São Paulo, São Paulo, SP (Filoni, Catão-Dias)
- Brazilian Institute for Conservation Medicine–TRÍADE, São Paulo, SP (Filoni, Silva, Marvulo)
- Laboratory of Molecular and Cellular Biology, Veterinary Medicine, Paulista University, São Paulo, SP (Filoni, de Carvalho, Coutinho)
- São Paulo Zoological Park Foundation, São Paulo, SP (Catão-Dias, Corrêa, Marques)
- Mata Ciliar Association, Jundiaí, SP (Adania)
| | - Hans Lutz
- Department of Pathology, Faculty of Veterinary Medicine and Zootechny, University of São Paulo, São Paulo, SP (Filoni, Catão-Dias)
- Brazilian Institute for Conservation Medicine–TRÍADE, São Paulo, SP (Filoni, Silva, Marvulo)
- Laboratory of Molecular and Cellular Biology, Veterinary Medicine, Paulista University, São Paulo, SP (Filoni, de Carvalho, Coutinho)
- São Paulo Zoological Park Foundation, São Paulo, SP (Catão-Dias, Corrêa, Marques)
- Mata Ciliar Association, Jundiaí, SP (Adania)
| | - Regina Hofmann-Lehmann
- Department of Pathology, Faculty of Veterinary Medicine and Zootechny, University of São Paulo, São Paulo, SP (Filoni, Catão-Dias)
- Brazilian Institute for Conservation Medicine–TRÍADE, São Paulo, SP (Filoni, Silva, Marvulo)
- Laboratory of Molecular and Cellular Biology, Veterinary Medicine, Paulista University, São Paulo, SP (Filoni, de Carvalho, Coutinho)
- São Paulo Zoological Park Foundation, São Paulo, SP (Catão-Dias, Corrêa, Marques)
- Mata Ciliar Association, Jundiaí, SP (Adania)
| |
Collapse
|
17
|
Development and application of a universal Hemoplasma screening assay based on the SYBR green PCR principle. J Clin Microbiol 2009; 47:4049-54. [PMID: 19828748 DOI: 10.1128/jcm.01478-09] [Citation(s) in RCA: 55] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Hemotropic mycoplasmas (hemoplasmas) are the causative agents of infectious anemia in several mammalian species. Their zoonotic potential has recently been substantiated by the identification of a feline hemoplasma isolate in an immunocompromised human patient. Although species-specific diagnostic molecular methods have been developed, their application as screening tools is limited due to the species diversity of hemoplasmas. The goals of this study were to develop a universal hemoplasma screening assay with broad specificity based on the SYBR green PCR principle, to compare the assay with hemoplasma-specific TaqMan PCR, and to analyze potential tick vectors and human blood samples to address the zoonotic potential. The newly developed PCR assay based on the 16S rRNA gene amplified feline, canine, bovine, porcine, camelid, and murine hemoplasmas, as well as Mycoplasma penetrans and Mycoplasma pneumoniae. The lower detection limit for feline and canine hemoplasmas was 1 to 10 copies/PCR. The assay exhibited 98.2% diagnostic sensitivity and 92.1% diagnostic specificity for feline hemoplasmas. All 1,950 Ixodes ticks were PCR negative, suggesting that Ixodes ticks are not relevant vectors for the above-mentioned hemoplasma species in Switzerland. None of the 414 blood samples derived from anemic or immunocompromised human patients revealed a clear positive result. The SYBR green PCR assay described here is a suitable tool to screen for known and so-far-undiscovered hemoplasma species. Positive results should be confirmed by specific TaqMan PCR or sequencing.
Collapse
|
18
|
Lutz H, Addie D, Belák S, Boucraut-Baralon C, Egberink H, Frymus T, Gruffydd-Jones T, Hartmann K, Hosie MJ, Lloret A, Marsilio F, Pennisi MG, Radford AD, Thiry E, Truyen U, Horzinek MC. Feline leukaemia. ABCD guidelines on prevention and management. J Feline Med Surg 2009; 11:565-74. [PMID: 19481036 PMCID: PMC7172531 DOI: 10.1016/j.jfms.2009.05.005] [Citation(s) in RCA: 98] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Abstract
OVERVIEW Feline leukaemia virus (FeLV) is a retrovirus that may induce depression of the immune system, anaemia and/or lymphoma. Over the past 25 years, the prevalence of FeLV infection has decreased considerably, thanks both to reliable tests for the identification of viraemic carriers and to effective vaccines. INFECTION Transmission between cats occurs mainly through friendly contacts, but also through biting. In large groups of non-vaccinated cats, around 30-40% will develop persistent viraemia, 30-40% show transient viraemia and 20-30% seroconvert. Young kittens are especially susceptible to FeLV infection. DISEASE SIGNS The most common signs of persistent FeLV viraemia are immune suppression, anaemia and lymphoma. Less common signs are immune-mediated disease, chronic enteritis, reproductive disorders and peripheral neuropathies. Most persistently viraemic cats die within 2-3 years. DIAGNOSIS In low-prevalence areas there may be a risk of false-positive results; a doubtful positive test result in a healthy cat should therefore be confirmed, preferably by PCR for provirus. Asymptomatic FeLV-positive cats should be retested. DISEASE MANAGEMENT Supportive therapy and good nursing care are required. Secondary infections should be treated promptly. Cats infected with FeLV should remain indoors. Vaccination against common pathogens should be maintained. Inactivated vaccines are recommended. The virus does not survive for long outside the host. VACCINATION RECOMMENDATIONS All cats with an uncertain FeLV status should be tested prior to vaccination. All healthy cats at potential risk of exposure should be vaccinated against FeLV. Kittens should be vaccinated at 8-9 weeks of age, with a second vaccination at 12 weeks, followed by a booster 1 year later. The ABCD suggests that, in cats older than 3-4 years of age, a booster every 2-3 years suffices, in view of the significantly lower susceptibility of older cats.
Collapse
Affiliation(s)
- Hans Lutz
- European Advisory Board on Cat Diseases (ABCD).
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Guiot AL, Cariou C, Krogmann V, Thibault JC, Poulet H. Compatibility between a rabies vaccine and a combined vaccine against feline rhinotracheitis, fcv
, fplv
and f
elv
, and Chlamydophila felis. Vet Rec 2008; 162:690-2. [DOI: 10.1136/vr.162.21.690] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Affiliation(s)
- A. L. Guiot
- CPB; 2, place des Quatre Vierges 69110 Sainte Foy Les Lyon France
| | - C. Cariou
- Merial, 254, rue Marcel Merieux 69007 Lyon France
| | - V. Krogmann
- Merial, 254, rue Marcel Merieux 69007 Lyon France
| | | | - H. Poulet
- Merial, 254, rue Marcel Merieux 69007 Lyon France
| |
Collapse
|
20
|
Kanellos T, Sutton DJ, Salisbury CF, Chalmers WSK. Combined administration in a single injection of a feline multivalent modified live vaccine against FHV, FCV, and FPLV together with a recombinant FeLV vaccine is both safe and efficacious for all four major feline viral pathogens. J Feline Med Surg 2008; 10:346-54. [PMID: 18448375 DOI: 10.1016/j.jfms.2008.02.001] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/07/2008] [Indexed: 01/06/2023]
Abstract
Nobivac Tricat, a lyophilised trivalent modified live attenuated vaccine is routinely used to protect cats against three commonly diagnosed feline viral pathogens namely herpesvirus, calicivirus and panleukopenia virus. The recognition of feline leukaemia virus (FeLV) as an important viral pathogen has prompted the development of an efficacious liquid recombinant subunit FeLV vaccine (p45 envelope protein). Lyophilised Tricat vaccine was dissolved in the liquid FeLV vaccine and no detectable deleterious effect on the titre of any of the live virus components was observed after 2h incubation. In vivo studies where the vaccines were mixed in the same syringe prior to inoculation showed no alteration to the safety profile assessed by repeat and overdose studies. Serological comparisons of the modified live viral antibody titres showed no evidence of reduced responses following administration of the mixed products. Challenge studies using pathogenic herpesvirus and FeLV revealed no difference in the degree of clinical protection. This paper shows that neither safety nor efficacy is adversely affected as a result of mixing the two vaccines.
Collapse
Affiliation(s)
- Theo Kanellos
- Agricultural University of Athens, Department of Anatomy and Physiology of Farm Animals, Faculty of Animal Science, Iera Odos 75, Athens 11855, Greece
| | | | | | | |
Collapse
|